
Suzanne Marie Noakes
Examiner (ID: 17824)
| Most Active Art Unit | 1656 |
| Art Unit(s) | 1656, 1653 |
| Total Applications | 1691 |
| Issued Applications | 1090 |
| Pending Applications | 193 |
| Abandoned Applications | 452 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5815000
[patent_doc_number] => 20060084678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-20
[patent_title] => 'Methods for identifying and using MarR family polypeptide binding compounds'
[patent_app_type] => utility
[patent_app_number] => 11/296017
[patent_app_country] => US
[patent_app_date] => 2005-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 88
[patent_figures_cnt] => 88
[patent_no_of_words] => 15655
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20060084678.pdf
[firstpage_image] =>[orig_patent_app_number] => 11296017
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/296017 | Methods for identifying and using MarR family polypeptide binding compounds | Dec 6, 2005 | Abandoned |
Array
(
[id] => 5865500
[patent_doc_number] => 20060099630
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-11
[patent_title] => 'NES-1 polypeptides, DNA, and related molecules and methods'
[patent_app_type] => utility
[patent_app_number] => 11/292215
[patent_app_country] => US
[patent_app_date] => 2005-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 11348
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20060099630.pdf
[firstpage_image] =>[orig_patent_app_number] => 11292215
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/292215 | NES-1 polypeptides, DNA, and related molecules and methods | Nov 29, 2005 | Abandoned |
Array
(
[id] => 5479617
[patent_doc_number] => 20090202574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'METHODS OF IMMUNE OR HAEMATOLOGICAL ENHANCEMENT, INHIBITING TUMOUR FORMATION OR GROWTH, AND TREATING OR PREVENTING CANCER'
[patent_app_type] => utility
[patent_app_number] => 11/719736
[patent_app_country] => US
[patent_app_date] => 2005-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 29378
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20090202574.pdf
[firstpage_image] =>[orig_patent_app_number] => 11719736
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/719736 | METHODS OF IMMUNE OR HAEMATOLOGICAL ENHANCEMENT, INHIBITING TUMOUR FORMATION OR GROWTH, AND TREATING OR PREVENTING CANCER | Nov 17, 2005 | Abandoned |
Array
(
[id] => 5865554
[patent_doc_number] => 20060099684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-11
[patent_title] => 'Novel antiangiogenic peptides'
[patent_app_type] => utility
[patent_app_number] => 11/263546
[patent_app_country] => US
[patent_app_date] => 2005-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16541
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20060099684.pdf
[firstpage_image] =>[orig_patent_app_number] => 11263546
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/263546 | Antiangiogenic peptides | Oct 30, 2005 | Issued |
Array
(
[id] => 5613909
[patent_doc_number] => 20060115837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-01
[patent_title] => 'Crystals and structure of domain III of West Nile Virus envelope protein in association with a Fab fragment of a neutralizing antibody'
[patent_app_type] => utility
[patent_app_number] => 11/251227
[patent_app_country] => US
[patent_app_date] => 2005-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 113652
[patent_no_of_claims] => 86
[patent_no_of_ind_claims] => 31
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20060115837.pdf
[firstpage_image] =>[orig_patent_app_number] => 11251227
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/251227 | Crystals and structure of domain III of West Nile Virus envelope protein in association with a Fab fragment of a neutralizing antibody | Oct 13, 2005 | Issued |
Array
(
[id] => 5800369
[patent_doc_number] => 20060035336
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-16
[patent_title] => 'Prokaryotic collagen-like proteins and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/245689
[patent_app_country] => US
[patent_app_date] => 2005-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 15136
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20060035336.pdf
[firstpage_image] =>[orig_patent_app_number] => 11245689
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/245689 | Prokaryotic collagen-like proteins and uses thereof | Oct 6, 2005 | Issued |
Array
(
[id] => 4808116
[patent_doc_number] => 20080171694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-17
[patent_title] => 'Pharmaceutical Formulation Comprising Crystalline Insulin and Dissolved Insulin'
[patent_app_type] => utility
[patent_app_number] => 11/664407
[patent_app_country] => US
[patent_app_date] => 2005-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4147
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20080171694.pdf
[firstpage_image] =>[orig_patent_app_number] => 11664407
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/664407 | Pharmaceutical formulation comprising crystalline insulin and dissolved insulin | Oct 4, 2005 | Issued |
Array
(
[id] => 5304222
[patent_doc_number] => 20090298874
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-03
[patent_title] => 'BACTERIAL ATP SYNTHASE BINDING DOMAIN'
[patent_app_type] => utility
[patent_app_number] => 11/576023
[patent_app_country] => US
[patent_app_date] => 2005-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 55329
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20090298874.pdf
[firstpage_image] =>[orig_patent_app_number] => 11576023
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/576023 | Bacterial ATP synthase binding domain | Sep 27, 2005 | Issued |
Array
(
[id] => 151580
[patent_doc_number] => 07683032
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-03-23
[patent_title] => 'Deglycosylated and desialidated long pentraxin PTX3'
[patent_app_type] => utility
[patent_app_number] => 11/575346
[patent_app_country] => US
[patent_app_date] => 2005-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3385
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/683/07683032.pdf
[firstpage_image] =>[orig_patent_app_number] => 11575346
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/575346 | Deglycosylated and desialidated long pentraxin PTX3 | Sep 27, 2005 | Issued |
Array
(
[id] => 5148795
[patent_doc_number] => 20070048855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-01
[patent_title] => 'Variants and chemically-modified variants of phenylalanine ammonia-lyase'
[patent_app_type] => utility
[patent_app_number] => 11/230374
[patent_app_country] => US
[patent_app_date] => 2005-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 46322
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20070048855.pdf
[firstpage_image] =>[orig_patent_app_number] => 11230374
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/230374 | Variants and chemically-modified variants of phenylalanine ammonia-lyase | Sep 18, 2005 | Issued |
Array
(
[id] => 5069476
[patent_doc_number] => 20070190578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-16
[patent_title] => 'Method of site specific labeling of proteins and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 11/228077
[patent_app_country] => US
[patent_app_date] => 2005-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8574
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20070190578.pdf
[firstpage_image] =>[orig_patent_app_number] => 11228077
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/228077 | Method of site specific labeling of proteins and uses therefor | Sep 15, 2005 | Abandoned |
Array
(
[id] => 5827786
[patent_doc_number] => 20060063149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-23
[patent_title] => 'Compositions and methods for detecting pathogen infection'
[patent_app_type] => utility
[patent_app_number] => 11/220372
[patent_app_country] => US
[patent_app_date] => 2005-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 46
[patent_no_of_words] => 36523
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20060063149.pdf
[firstpage_image] =>[orig_patent_app_number] => 11220372
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/220372 | Compositions and methods for detecting pathogen infection | Sep 5, 2005 | Abandoned |
Array
(
[id] => 425256
[patent_doc_number] => 07271239
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-09-18
[patent_title] => 'D-isomers of antimicrobial peptide'
[patent_app_type] => utility
[patent_app_number] => 11/213245
[patent_app_country] => US
[patent_app_date] => 2005-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 10614
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/271/07271239.pdf
[firstpage_image] =>[orig_patent_app_number] => 11213245
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/213245 | D-isomers of antimicrobial peptide | Aug 25, 2005 | Issued |
Array
(
[id] => 672402
[patent_doc_number] => 07091318
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-08-15
[patent_title] => 'mmFP encoding nucleic acids, polypeptides, antibodies and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/208927
[patent_app_country] => US
[patent_app_date] => 2005-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 16268
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/091/07091318.pdf
[firstpage_image] =>[orig_patent_app_number] => 11208927
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/208927 | mmFP encoding nucleic acids, polypeptides, antibodies and methods of use thereof | Aug 21, 2005 | Issued |
Array
(
[id] => 350365
[patent_doc_number] => 07496489
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-02-24
[patent_title] => 'Design of progesterone receptor ligands'
[patent_app_type] => utility
[patent_app_number] => 11/208303
[patent_app_country] => US
[patent_app_date] => 2005-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 82892
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 346
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/496/07496489.pdf
[firstpage_image] =>[orig_patent_app_number] => 11208303
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/208303 | Design of progesterone receptor ligands | Aug 18, 2005 | Issued |
Array
(
[id] => 5924976
[patent_doc_number] => 20060241285
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-26
[patent_title] => 'Crystals and structure of Synagis Fab'
[patent_app_type] => utility
[patent_app_number] => 11/207142
[patent_app_country] => US
[patent_app_date] => 2005-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 20281
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20060241285.pdf
[firstpage_image] =>[orig_patent_app_number] => 11207142
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/207142 | Crystals and structure of Synagis Fab | Aug 16, 2005 | Issued |
Array
(
[id] => 5558266
[patent_doc_number] => 20090269843
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-29
[patent_title] => 'Hemopexin fusion proteins'
[patent_app_type] => utility
[patent_app_number] => 11/660715
[patent_app_country] => US
[patent_app_date] => 2005-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17986
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20090269843.pdf
[firstpage_image] =>[orig_patent_app_number] => 11660715
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/660715 | Hemopexin fusion proteins | Aug 15, 2005 | Abandoned |
Array
(
[id] => 4484354
[patent_doc_number] => 07869958
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-01-11
[patent_title] => 'Structure-based modulators of B1 G-protein coupled receptors'
[patent_app_type] => utility
[patent_app_number] => 11/199821
[patent_app_country] => US
[patent_app_date] => 2005-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 12
[patent_no_of_words] => 32065
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/869/07869958.pdf
[firstpage_image] =>[orig_patent_app_number] => 11199821
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/199821 | Structure-based modulators of B1 G-protein coupled receptors | Aug 8, 2005 | Issued |
Array
(
[id] => 5515320
[patent_doc_number] => 20090215627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'Crystal Structure of Biotin Carboxylase (Bc) Domain of Acetyl-Coenzyme a Carboxylase and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/573217
[patent_app_country] => US
[patent_app_date] => 2005-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 19112
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20090215627.pdf
[firstpage_image] =>[orig_patent_app_number] => 11573217
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/573217 | Crystal Structure of Biotin Carboxylase (Bc) Domain of Acetyl-Coenzyme a Carboxylase and Methods of Use Thereof | Aug 2, 2005 | Abandoned |
Array
(
[id] => 5813929
[patent_doc_number] => 20060084090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-20
[patent_title] => 'Modulation of interaction between Nod1 and Gram-negative bacteria by Nod1 response to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island (cagPAI)'
[patent_app_type] => utility
[patent_app_number] => 11/195696
[patent_app_country] => US
[patent_app_date] => 2005-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 19007
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20060084090.pdf
[firstpage_image] =>[orig_patent_app_number] => 11195696
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/195696 | Modulation of interaction between Nod1 and Gram-negative bacteria by Nod1 response to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island (cagPAI) | Aug 2, 2005 | Abandoned |